Panel discussion: COVID-19 – Looking into the Future

A. Simonds (London, United Kingdom), G. C. Khilnani (New Delhi, India), J. Chalmers (Dundee, United Kingdom), D. J. Christopher (Vellore, India), S. Joshi (India)

Source: ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation

Number: 0

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Simonds (London, United Kingdom), G. C. Khilnani (New Delhi, India), J. Chalmers (Dundee, United Kingdom), D. J. Christopher (Vellore, India), S. Joshi (India). Panel discussion: COVID-19 – Looking into the Future. ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Panel discussion on long COVID – what we know and future perspectives Source: ERS webinar 2022: Panel discussion on long COVID – what we know and future perspectives Year: 2022
Perspectives of the management of COVID-19 infection in China Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China Year: 2020
Interview on Coronavirus COVID-19 management experience in China Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China Year: 2020
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Year: 2020
ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Year: 2020
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Year: 2020
Development of RSV vaccines: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019
Outlook: Future developments for the diagnosis of MTB infection Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course Year: 2008
Understanding new vaccines for SARS-CoV-2 and their regulation Source: ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation Year: 2021
Panel discussion: elevating respiratory diseases to the top of the political agenda Source: Virtual Congress 2021 – Transforming respiratory care: why now is the time to act Year: 2021
SARS-CoV-2 (COVID-19): Research response Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response Year: 2020
Post-genome respiratory epidemiology: a multidisciplinary challenge Source: Eur Respir J 2004; 24: 471-480 Year: 2004
Panel discussion: identify concrete areas/topics where collaboration at EU-level is necessary. Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013
Evidence-based clinical algorithms for CAP: where do we stand? Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021
The role of virus infections in asthma: immune responses and future possibilities Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007
COVID-19: Q and A Source: ERS Webinar 2020: COVID-19: Q and A Year: 2020